Stem Cell Therapeutics - News & Events


	PRESS RELEASES EVENTS PRESENTATIONS LINKS

PRESS RELEASES

Currently Viewing:


Aug 26, 2010	Stem Cell Therapeutics Corp. Announces Q2 2010 Financial Results
Aug 13, 2010	Stem Cell Therapeutics Corp.: Traumatic Brain Injury (TBI) Clinical Study Gains IRB Approval at University of Calgary
Aug 10, 2010	Stem Cell Therapeutics Corp.: Corporate Update
Jun 25, 2010	Stem Cell Therapeutics Corp. Corporate Update
Jun 17, 2010	Stem Cell Therapeutics Corp. Continues Its Validation Review of the Modified REGENESIS Phase IIb Stroke Trial
Jun 08, 2010	Stem Cell Therapeutics Corp. Announces the Issuance of United States Patent
May 25, 2010	Stem Cell Therapeutics Corp. Announces Top-Line Results for the Modified REGENESIS Phase IIb Stroke Trial
May 19, 2010	Stem Cell Therapeutics Corp. Announces Voting Results and Q1 2010 Financial Results
May 19, 2010	Stem Cell Therapeutics Corp. Announces the Date for the Release of Top-Line Results in the Modified REGENESIS Phase IIb Stroke Trial
Apr 28, 2010	Stem Cell Therapeutics Corp. Announces the Publication of a Dundee Capital Markets Report: SSS- Stem Cell Therapeutics Corp.- Near Term High Risk/Reward Data

STOCK QUOTE


Symbol:	TSX:SSS
Last Trade:	0.065
Change:	+8.33%
Volume:	243549
Date:	9/3/2010
Time:	3:48pm
Note: Quotes are delayed. For informational purposes only.

	LETTER TO SHAREHOLDERS
	+ 2009 Letter to Shareholders

	FACT SHEET

©2004 - 2010 Stem Cell Therapeutics - All rights reserved

Home | Site Map | Terms Of Use | Contact Us